Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax™) to the Drug (Everolimus) -Eluting Stent (Synergy™) in Acute Coronary Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1800 participants.
Also called NCT02049229
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,800 participants
- Sponsor
- The Hospital District of Satakunta
- Registry
-
NCT02049229
-
- Other papers using this trial's data
- Titanium-Nitride-Oxide-Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome: The Randomized TIDES-ACS Trial
- Titanium-Nitride-Oxide-Coated vs Everolimus-Eluting Stents in Acute Coronary Syndrome: 5-Year Clinical Outcomes of the TIDES-ACS Randomized Clinical Trial
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Finland
- Registry status
- Unknown status
Technical summary
Registry record NCT02049229. Randomized; single masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2015-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax™) to the Drug (Everolimus) -Eluting Stent (Synergy™) in Acute Coronary Syndrome
- Acronym
- TIDES-ACS
- Condition
- Myocardial Infarction
- Condition
- Percutaneous Coronary Intervention
- Condition
- Atherosclerosis
- Intervention (Device)
- percutaneous coronary intervention
- Intervention (Device)
- percutaneous coronary intervention
- Lead sponsor
- The Hospital District of Satakunta
Record details
- Record id
cardio:ct-nct02049229- Content hash
a7895e829c169c4b6bbb1c2a12424c551769c057804006bb0cefdef6a6bc0698